Literature DB >> 15570627

COPCORD--an unrecognized fountainhead of community rheumatology in developing countries.

Arvind Chopra.   

Abstract

Mesh：

Year:  2004        PMID： 15570627

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  15 in total

Review 1.  Rheumatology in India--quo vadis?

Authors:  Rohini Handa
Journal:  Nat Rev Rheumatol       Date:  2014-11-04       Impact factor: 20.543

2.  Effect of ethnic origin (Caucasians versus Turks) on the prevalence of rheumatic diseases: a WHO-ILAR COPCORD urban study in Iran.

Authors:  Fereydoun Davatchi; Ahmad-Reza Jamshidi; Arash Tehrani Banihashemi; Jaleh Gholami; Mohammad Hossein Forouzanfar; Massoomeh Akhlaghi; Mojgan Barghamdi; Elham Noorolahzadeh; Ali-Reza Khabazi; Mansour Salesi; Amir-Hossein Salari; Mansoor Karimifar; Kamal Essalat-Manesh; Mehrzad Hajialiloo; Mohsen Soroosh; Farhad Farzad; Hamid-Reza Moussavi; Farideh Samadi; Koorosh Ghaznavi; Homa Asgharifard; Amir-Hossein Zangiabadi; Farhad Shahram; Abdolhadi Nadji; Mahmood Akbarian; Farhad Gharibdoost; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2009-07-26       Impact factor: 2.980

3.  Impact of musculoskeletal pain on physical function and health-related quality of life in a rural community in south India: a WHO-ILAR-COPCORD-BJD India study.

Authors:  Ashish Jacob Mathew; Arvind Chopra; Dany Varughese Thekkemuriyil; Elizabeth George; Vinay Goyal; Jayakumar Bhaskaran Nair
Journal:  Clin Rheumatol       Date:  2011-08-19       Impact factor: 2.980

Review 4.  The burden of musculoskeletal disease--a global perspective.

Authors:  Peter M Brooks
Journal:  Clin Rheumatol       Date:  2006-04-12       Impact factor: 2.980

Review 5.  The WHO-ILAR COPCORD Bhigwan (India) model: foundation for a future COPCORD design and data repository.

Authors:  Arvind Chopra
Journal:  Clin Rheumatol       Date:  2006-04-13       Impact factor: 2.980

6.  The prevalence of musculoskeletal complaints in a rural area in Iran: a WHO-ILAR COPCORD study (stage 1, rural study) in Iran.

Authors:  Fereydoun Davatchi; Arash Tehrani Banihashemi; Jaleh Gholami; Seyedeh Tahereh Faezi; Mohammad Hossein Forouzanfar; Mansour Salesi; Mansour Karimifar; Kamal Essalatmanesh; Mojgan Barghamdi; Elham Noorolahzadeh; Saideh Dahaghin; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2009-07-23       Impact factor: 2.980

7.  Prevalence of musculoskeletal disorders and rheumatic diseases in Cuenca, Ecuador: a WHO-ILAR COPCORD study.

Authors:  Sergio Guevara-Pacheco; Astrid Feicán-Alvarado; Luz Helena Sanín; Jaime Vintimilla-Ugalde; Fernando Vintimilla-Moscoso; Jorge Delgado-Pauta; Angelita Lliguisaca-Segarra; Holger Dután-Erráez; Daniel Guevara-Mosquera; Verónica Ochoa-Robles; Mario H Cardiel; Ingris Peláez-Ballestas
Journal:  Rheumatol Int       Date:  2016-03-29       Impact factor: 2.631

8.  A call to integrate musculoskeletal disorders into the national programme for non-communicable diseases (NCD).

Authors:  Ashish J Mathew; Asma Rahim; Thomas Bina; Binoy J Paul; Arvind Chopra
Journal:  Indian J Med Res       Date:  2012-09       Impact factor: 2.375

9.  A national survey of musculoskeletal impairment in Rwanda: prevalence, causes and service implications.

Authors:  Oluwarantimi Atijosan; Dorothea Rischewski; Victoria Simms; Hannah Kuper; Bonaventure Linganwa; Assuman Nuhi; Allen Foster; Chris Lavy
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

10.  Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey.

Authors:  Jaime C Branco; Ana M Rodrigues; Nélia Gouveia; Mónica Eusébio; Sofia Ramiro; Pedro M Machado; Leonor Pereira da Costa; Ana Filipa Mourão; Inês Silva; Pedro Laires; Alexandre Sepriano; Filipe Araújo; Sónia Gonçalves; Pedro S Coelho; Viviana Tavares; Jorge Cerol; Jorge M Mendes; Loreto Carmona; Helena Canhão
Journal:  RMD Open       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.